J L Ziegler. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useBCG VaccineBurkitt Lymphoma/cerebrospinal fluidBurkitt Lymphoma/drug therapyCell Transformation, NeoplasticCyclophosphamide/administration & dosageCyclophosphamide/therapeutic useCytarabine/therapeutic useFollow-Up StudiesHumansImmunotherapyMethotrexate/therapeutic useNitrosourea Compounds/therapeutic usePrognosisRemission, SpontaneousTime FactorsVincristine/therapeutic use
Substances: See more » Antineoplastic AgentsBCG VaccineNitrosourea CompoundsCytarabineVincristineCyclophosphamideMethotrexate
Year: 1972 PMID: 4641762 DOI: 10.1002/1097-0142(197212)30:6<1534::aid-cncr2820300619>3.0.co;2-6
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860